[EN] INHIBITORS OF HEPATITIS C VIRUS<br/>[FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
申请人:GILEAD SCIENCES INC
公开号:WO2014008285A1
公开(公告)日:2014-01-09
Compounds of Formula I are disclosed, As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
化合物I的结构已经披露,以及其药用盐。还披露了使用这些化合物的方法和含有这些化合物的药物组合物。
INHIBITORS OF HEPATITIS C VIRUS
申请人:Gilead Sciences, Inc.
公开号:EP3159345A1
公开(公告)日:2017-04-26
Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed:
The compounds are useful in the treatment of Hepatitis C infections.
本研究公开了式(IV)化合物及其药学上可接受的盐类:
这些化合物可用于治疗丙型肝炎感染。
INTERMEDIATES FOR PREPARING INHIBITORS OF HEPATITIS C VIRUS
申请人:Gilead Sciences, Inc.
公开号:EP3492464A1
公开(公告)日:2019-06-05
Intermediates, used for preparing inhibitors of the hepatitis C virus, of the following formulae are disclosed
公开了用于制备丙型肝炎病毒抑制剂的下列配方的中间体
Etchant, replenishment solution and method for forming copper wiring
申请人:MEC COMPANY LTD.
公开号:US10174428B2
公开(公告)日:2019-01-08
An etchant for copper includes an acid and one or more compounds selected from the group consisting of an aliphatic noncyclic compound, an aliphatic heterocyclic compound and a heteroaromatic compound. The aliphatic noncyclic compound is a saturated aliphatic noncyclic compound (A) including only two or more nitrogen atoms as heteroatoms, and 2 to 10 carbon atoms. The aliphatic heterocyclic compound is a compound (B) including a five-, six-, or seven-membered ring having one or more nitrogen atoms as one or more heteroatoms constituting the ring. The heteroaromatic compound is a compound (C) including a six-membered heteroaromatic ring having one or more nitrogen atoms as one or more heteroatoms constituting the ring.